Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-21-143099
Filing Date
2021-11-23
Accepted
2021-11-23 17:14:29
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 tm2133559-1_424b5.htm 424B5 1006530
2 GRAPHIC lg_beigene-4c.jpg GRAPHIC 424662
3 GRAPHIC lg_beigenenew-4c.jpg GRAPHIC 27888
  Complete submission text file 0001104659-21-143099.txt   1581587
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

EIN.: 981209416 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-238181 | Film No.: 211439668
SIC: 2834 Pharmaceutical Preparations